We are live on ! Find out more
FBT icon

First Trust NYSE Arca Biotechnology Index Fund
FBT

253 hedge funds and large institutions have $546M invested in First Trust NYSE Arca Biotechnology Index Fund in 2025 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 75 increasing their positions, 86 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 20

7% more capital invested

Capital invested by funds: $510M → $546M (+$36M)

1% more funds holding

Funds holding: 250 → 253 (+3)

0.68% less ownership

Funds ownership: 50.59% → 49.91% (-0.68%)

13% less repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 86

Holders
253
Holders Change
+3
Holders Change %
+1.2%
% of All Funds
3.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
75
Reduced
86
Closed
20
Calls
$3.64M
Puts
–
Net Calls
+$3.64M
Net Calls Change
+$817K

Top Buyers

1
Citadel Advisors
Citadel Advisors
Florida
+$3.48M
2
Osaic Holdings
Osaic Holdings
Arizona
+$3M
3
NA
Navellier & Associates
Nevada
+$1.99M
4
Cetera Investment Advisers
Cetera Investment Advisers
Illinois
+$1.26M
5
LPL Financial
LPL Financial
California
+$1.17M

Top Sellers

1
Goldman Sachs
Goldman Sachs
New York
-$8.74M
2
AAS
Ameritas Advisory Services
Nebraska
-$6.17M
3
YC
Yarbrough Capital
Tennessee
-$5.03M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.59M
5
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$1.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
PTC
226
Private Trust Company
Ohio
$13.8K +$4.77K +28 +57%
HAP
227
Harbor Asset Planning
Massachusetts
$13.7K – – –
CMBA
228
C.M. Bidwell & Associates
Hawaii
$13.4K – – –
NSIM
229
North Star Investment Management
Illinois
$13.4K – – –
PSFG
230
Park Square Financial Group
Georgia
$10.9K -$31.2K -183 -75%
PCFFS
231
Pacific Center for Financial Services
California
$9.4K – – –
BDPWM
232
Barnes Dennig Private Wealth Management
Ohio
$8.96K – – –
CFB
233
Cullen/Frost Bankers
Texas
$8.96K +$8.52K +50 New
AA
234
Addison Advisors
Vermont
$7.35K – – –
PMFA
235
Plante Moran Financial Advisors
Michigan
$6.63K – – –
GEA
236
Glen Eagle Advisors
New Jersey
$5.38K – – –
TCPW
237
Twin City Private Wealth
North Carolina
$5.38K +$5.11K +30 New
OSAM
238
O'Shaughnessy Asset Management
Connecticut
$4.48K – – –
TSMHT
239
Thurston Springer Miller Herd & Titak
Indiana
$4.15K -$210K -1,234 -98%
DCM
240
Davis Capital Management
Florida
$3.94K +$3.75K +22 New
US Bancorp
241
US Bancorp
Minnesota
$3.59K -$8.52K -50 -71%
Q1WB
242
Quest 10 Wealth Builders
Virginia
$2.87K – – –
HI
243
Hoey Investments
Pennsylvania
$2.69K – – –
ANBT
244
American National Bank & Trust
Texas
$2.51K – – –
PA
245
Parallel Advisors
California
$2.33K – – –
C
246
Covestor
United Kingdom
$2K – – –
AIC
247
Archer Investment Corporation
Indiana
$1.8K – – –
DF
248
Dunhill Financial
United Kingdom
$1.63K – – –
ACA
249
Aptus Capital Advisors
Alabama
$359 – – –
LC
250
Luminist Capital
Michigan
$185 – – –
7 8 9
10
11

FBT Hedge Fund Activity: Q3 2025 in Review

253 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q3 2025, worth a combined $546M — up 7.1% from $510M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new FBT positions and 20 closed out — a net gain of 6 holders — while 75 added to existing stakes and 86 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $3.48M. The largest seller was Goldman Sachs, cutting an estimated $8.74M.

  • 253 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q3 2025, up from 250 in Q2 2025.
  • Funds reported $546M of First Trust NYSE Arca Biotechnology Index Fund stock for Q3 2025, up 7.1% quarter-over-quarter.
  • 26 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q3 2025 and 20 closed out, a net change of +6 holders.
  • The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q3 2025 was Citadel Advisors, an estimated $3.48M added.
  • The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q3 2025 was Goldman Sachs, an estimated $8.74M sold.

Based on aggregated 13F filings for Q3 2025.